Clinical Trial Update: The Contribution of Induced Glycolysis to the Exhaled Volatile Organic Compounds' (VOCs) Signature in Lung Cancer

View source ↗

Summary

This trial investigates whether induced glycolysis alters the exhaled volatile organic compounds signature in lung cancer, with the aim of identifying potential…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Cancer

Snippet

Sponsor: Sheba Medical Center | Conditions: Lung Cancer | Status: UNKNOWN